生物藥劑學
Biopharmaceutics
| 節 | 週三 |
|---|---|
1 08:00–08:50 | 生物藥劑學 YR101(陽明) 3 節連堂 |
2 09:00–09:50 | |
3 10:10–11:00 |
* 根據陽明交大上課時間表所列
教師未提供此項資料
教師未提供此項資料
無備註
教師未提供此項資料
教師未提供此項資料
教師未提供此項資料
| 週次 | 主題 |
|---|---|
| 第 1 週 | 1. Introduction to biopharmaceutics and pharmacokinetics (Ch.1) 2 hr 2. Mathematic fundamentals in pharmacokinetics (Ch.2) 2020/03/04 |
| 第 2 週 | One-compartment model (Ch.4) 2020/03/11 |
| 第 3 週 | Multicompartment models (Ch.5) 2020/03/18 |
| 第 4 週 | 1. Intravenous infusion (Ch.6) 2. Drug elimination, clearance, and renal clearance (Ch.7) 2020/03/25 |
| 第 5 週 | Quiz-1 Pharmacokinetics of oral absorption (Ch.8) Reading assignment-1 (report due by 2020/4/15) 2020/04/01 |
| 第 6 週 | Multiple-dosage regimens (Ch.9) 2020/04/08 |
| 第 7 週 | Nonlinear pharmacokinetics (Ch.10) 2020/04/15 |
| 第 8 週 | Midterm exam & Review 2020/04/22 |
| 第 9 週 | Physiologic drug distribution and protein binding (Ch.11) 2020/04/29 |
| 第 10 週 | Drug elimination and hepatic clearance (Ch.12) 2020/05/06 |
| 第 11 週 | Pharmacogenetics & drug metabolism (Ch.13) 2020/05/13 |
| 第 12 週 | 1. Physiologic factors related to drug absorption (Ch.14) 2. Biopharmaceutical considerations in drug product design and in vitro drug product performance (Ch.15) Reading assignment-2 (report due by 2020/6/3) 2020/05/20 |
| 第 13 週 | Bioavailability and Bioequivalence (Ch.16 & 17) 2020/05/27 |
| 第 14 週 | Relationship between Pharmacokinetics & Pharmacodynamics (Ch.21) 2020/06/03 |
| 第 15 週 | 1. Application of pharmacokinetics to clinical situation Ch.22) 2. Dose adjustment in renal and hepatic disease (Ch.24) 2020/06/10 |
| 第 16 週 | Final Exam 2020/06/17 |
| 第 17 週 | 彈性授課-1 (Reading assignment-1; assigned Week 5, report due in Week 7) 2020/06/24 |
| 第 18 週 | 彈性授課-2 (Reading assignment-2; assigned Week 12, report due in Week 14) 2020/07/01 |
教師未提供此項資料
- 地點
- 教師未提供此項資料
- 時間
- 教師未提供此項資料
- 聯絡方式
- 教師未提供此項資料
